MariaGKubaMDMD

PubMed

• 15 citations
  Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry.
  Charles J Robbins, Aileen I Fernandez, Gang Han, Serena Wong, Malini Harigopal, Mirna Podoll, Kamaljeet Singh, Amy Ly, M Gabriela Kuba, Hannah Wen, Mary Ann Sanders, J...> ;Modern Pathology. 2023 Jan 1
• 2 citations
  Update on lobular lesions of the breast.
  Maria Gabriela Kuba, Edi Brogi> ;Histopathology. 2023 Jan 1
• 4 citations
  Histopathologic Grading Is of Prognostic Significance in Primary Angiosarcoma of Breast: Proposal of a Simplified 2-tier Grading System.
  Maria G Kuba, Josephine K Dermawan, Bin Xu, Samuel Singer, George Plitas, William D Tap, Sandra P D'Angelo, Evan Rosenbaum, Edi Brogi, Cristina R Antonescu> ;The American Journal of Surgical Pathology. 2023 Mar 1
• 135 citations
  Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue.
  Aileen I Fernandez, Matthew Liu, Andrew Bellizzi, Jane Brock, Oluwole Fadare, Krisztina Hanley, Malini Harigopal, Julie M Jorns, M Gabriela Kuba, Amy Ly, Mirna Podoll,...> ;JAMA Oncology. 2022 Apr 1
• 11 citations
  Interobserver Variation of PD-L1 SP142 Immunohistochemistry Interpretation in Breast Carcinoma: A Study of 79 Cases Using Whole Slide Imaging.
  Raza S Hoda, Edi Brogi, Timothy M. D'Alfonso, Anne Grabenstetter, Dilip Giri, Matthew G. Hanna, M. Gabriela Kuba, Melissa Murray, Christina E Vallejo, Hong Zhang, Jorg...> ;Archives of Pathology & Laboratory Medicine. 2021 Sep 1
• 7 citations
  The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast
  Maria Gabriela Kuba, Bin Xu, Sandra P. D'Angelo, Evan Rosenbaum, George Plitas, Dara S. Ross, Edi Brogi, Cristina R. Antonescu> ;Histopathology. 2021 Jun 24
• 10 citations
  Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.
  M. Gabriela Kuba, Melissa Murray, Catarina Calle, Monica Morrow, Edi Brogi, Coffey, K. M., Kristen Coffey> ;Modern Pathology. 2021 Apr 6
• 18 citations
  Histopathologic features of breast cancer in Li–Fraumeni syndrome
  M. Gabriela Kuba, Susan C. Lester, Teresa Bowman, Samantha Stokes, Krishan Taneja, Judy Garber, Deborah A. Dillon> ;Modern Pathology. 2021 Mar 1
• 2 citations
  Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas.
  Catarina Calle, Maria Gabriela Kuba, Edi Brogi> ;The Breast Journal. 2020 Jun 1
• 91 citations
  Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
  Emily Reisenbichler, Gang Han, Andrew M. Bellizzi, Veerle Bossuyt, Jane E. Brock, Kimberly Cole, Oluwole Fadare, Omar Hameed, Krisztina Z. Hanley, Beth T. Harrison, M....> ;Modern Pathology. 2020 Apr 16
• 6 citations
  Hyperechoic malignancies of the breast: Underlying pathologic features correlating with this unusual appearance on ultrasound.
  Maria G. Kuba, Catherine S. Giess, Tad J. Wieczorek, Susan C. Lester> ;The Breast Journal. 2020 Apr 1
• 4 citations
  Erratum for the research article: Genomic proling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance...
  Jennifer M. Giltnane, Katherine E. Hutchinson, Thomas Stricker, Luigi Formisano, Christian D. Young, Monica V. Estrada, Mellissa J. Nixon, Liping Du, Violeta Sanchez, ...> ;Science Translational Medicine. 2019 Feb 13
• 13 citations
  Fibromatosis of the Breast: Diagnostic Accuracy of Core Needle Biopsy.
  M. Gabriela Kuba, Susan C. Lester, Catherine S. Giess, Monica M. Bertagnolli, Tad J. Wieczorek, Jane E. Brock> ;American Journal of Clinical Pathology. 2017 Sep 1
• 83 citations
  Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance
  Jennifer M. Giltnane, Katherine E. Hutchinson, Thomas Stricker, Luigi Formisano, Christian D. Young, Monica V. Estrada, Mellissa J. Nixon, Liping Du, Violeta Sanchez, ...> ;Science Translational Medicine. 2017 Aug 9
• 57 citations
  A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC): Respons...
  Bojana Jovanovic, Ingrid A. Mayer, Erica L. Mayer, Vandana G. Abramson, Aditya Bardia, Melinda E. Sanders, M. Gabriela Kuba, Monica V. Estrada, J. Scott Beeler, Timoth...> ;Clinical Cancer Research. 2017 Aug 1
• 3 citations
  Primary Carcinoid Tumor of the Renal Pelvis Arising From Intestinal Metaplasia: An Unusual Histogenetic Pathway?
  Maria G. Kuba, Allison Wasserman, Cindy L. Vnencak-Jones, Julia A. Bridge, Lan L. Gellert, Omar Hameed, Giovanna A. Giannico> ;Applied Immunohistochemistry & Molecular Morphology. 2017 Aug 1
• 17 citations
  Lethal neonatal meningoencephalitis caused by multi-drug resistant, highly virulent Escherichia coli
  Junaid Iqbal, Kevin R. Dufendach, John C. Wellons, Maria G. Kuba, Hilary Highfield Nickols, Oscar G. Gómez-Duarte, James L. Wynn> ;Infectious Diseases. 2016 Feb 19
• 9 citations
  ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma
  Katherine E. Hutchinson, Douglas B. Johnson, A. Johnson, Violeta Sanchez, Maria G. Kuba, Pengcheng Lu, Xi Chen, Mark C. Kelley, Qingguo Wang, Zhongming Zhao, Mark G. K...> ;Oncotarget. 2015 Jun 13
• 27 citations
  LYN-activating mutations mediate antiestrogen resistance in estrogen receptor–positive breast cancer
  Luis J. Schwarz, Emily M. Fox, Justin M. Balko, Joan T. Garrett, Maria G. Kuba, Monica V. Estrada, Ana M. Gonzalez-Angulo, Gordon B. Mills, Monica Red-Brewer, Ingrid A...> ;The Journal of Clinical Investigation. 2014 Dec 1
• 129 citations
  Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Rece...
  Ingrid A. Mayer, Vandana G. Abramson, Steven J. Isakoff, Andres Forero, Justin M. Balko, Maria G. Kuba, Melinda E. Sanders, Jeffrey T. Yap, Annick D. Van den Abbeele, ...> ;Journal of Clinical Oncology. 2014 Apr 20
• 357 citations
  Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets
  Justin M. Balko, Jennifer M. Giltnane, Kai Wang, Luis J. Schwarz, Christian D. Young, Rebecca S. Cook, Philip Owens, Melinda E. Sanders, Maria G. Kuba, Violeta Sanchez...> ;Cancer Discovery. 2014 Feb 1
• 43 citations
  ErbB3 downregulation enhances luminal breast tumor response to antiestrogens
  Meghan M. Morrison, Katherine E. Hutchinson, Michelle M. Williams, Jamie C. Stanford, Justin M. Balko, Christian D. Young, Maria G. Kuba, Violeta Sanchez, Andrew Willi...> ;The Journal of Clinical Investigation. 2013 Oct 1
• 143 citations
  Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies
  Ariella B. Hanker, Adam D. Pfefferle, Justin M. Balko, Maria G. Kuba, Christian D. Young, Violeta Sanchez, Cammie R. Sutton, Hailing Cheng, Charles M. Perou, Jean J. Z...> ;Proceedings of the National Academy of Sciences of the United States of America. 2013 Aug 27
• 67 citations
  Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation
  Emily M. Fox, Maria G. Kuba, Todd W. Miller, Barry R. Davies, Carlos L. Arteaga> ;Breast Cancer Research. 2013 Jul 11
• 89 citations
  Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer
  Jennifer B. Dennison, Jennifer R. Molina, Shreya Mitra, Ana M. Gonzalez-Angulo, Justin M. Balko, Maria G. Kuba, Melinda E. Sanders, Joseph A. Pinto, Henry L. Gomez, Ca...> ;Clinical Cancer Research. 2013 Jul 1
• Join now to see all